Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,29,0.96 [0.92-1.01],0.0968012578698473
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",Inverse variance weighted,29,0.96 [0.89-1.03],0.25504664283526
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,29,1.11 [0.86-1.43],0.44141697374868
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,29,1.01 [0.90-1.13],0.889818521694715
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,29,0.93 [0.63-1.38],0.721401161303885
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,29,0.87 [0.72-1.06],0.160792808762219
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,29,0.91 [0.81-1.03],0.145376721766589
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,29,1.05 [0.86-1.29],0.613785126584463
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,29,1.05 [0.80-1.38],0.735293304797213
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",Inverse variance weighted,29,0.96 [0.89-1.04],0.367364478130836
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,Inverse variance weighted,29,1.19 [0.71-1.98],0.50953625164003
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,29,1.03 [0.97-1.09],0.332277561357769
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,29,1.00 [0.95-1.05],0.933189823237994
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,29,1.01 [0.81-1.26],0.906025356339343
ACP5,Tartrate-resistant acid phosphatase type 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,29,0.96 [0.81-1.14],0.658924551337875
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,29,1.01 [0.93-1.10],0.738956953734565
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,Inverse variance weighted,29,1.00 [0.95-1.06],0.961674270449053
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,29,1.00 [0.95-1.06],0.948263296089222
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,29,1.00 [0.95-1.05],0.878677242184232
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,29,1.02 [0.95-1.10],0.51176673615498
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,29,1.04 [0.96-1.13],0.323956526772442
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,29,1.11 [0.84-1.45],0.473844752236643
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,29,1.03 [0.77-1.37],0.852037646245902
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,29,0.97 [0.83-1.13],0.671449116548098
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,29,0.95 [0.84-1.08],0.439787429732862
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,29,0.98 [0.92-1.04],0.477460560619059
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,29,0.96 [0.82-1.14],0.662661691340172
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,29,0.90 [0.78-1.05],0.191828469167078
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,29,1.01 [0.81-1.25],0.951567306418197
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,29,0.92 [0.64-1.32],0.645250190236196
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,29,0.91 [0.81-1.02],0.104322651025273
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,29,0.96 [0.77-1.19],0.690581051138925
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,29,0.97 [0.91-1.03],0.324571945216115
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,29,0.96 [0.90-1.02],0.166905888820903
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,29,0.96 [0.85-1.07],0.444141197980639
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,29,0.97 [0.86-1.08],0.546807876181905
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,29,0.82 [0.61-1.10],0.18619795159652
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,29,0.84 [0.72-0.98],0.0232038098614311
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,29,0.99 [0.95-1.04],0.775203950642833
ACP5,Tartrate-resistant acid phosphatase type 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,29,0.99 [0.80-1.22],0.920648406626765
